Skip to content

The effect of adjunctive triple antibiotic paste in deep periodontal pocket management: a comprehensive investigation of clinical, immunological and microbiological outcomes through a randomised controlled trial

The effect of adjunctive triple antibiotic paste in deep periodontal pocket management: a comprehensive investigation of clinical, immunological and microbiological outcomes through a randomised controlled trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN58670024
Enrollment
30
Registered
2025-01-05
Start date
2025-01-03
Completion date
Unknown
Last updated
2025-01-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Periodontitis Oral Health

Interventions

This research will be a randomized (clinical) controlled trial (RCT) to compare the effectiveness of Triple Antibiotic Paste (TAP) as adjunctive with a control group receiving conventional periodontal
which is scaling and root surface debridement. Patients will be randomly allocated into two groups: one receiving Triple Antibiotic Paste (TAP) and the other receiving conventional periodontal ther

Sponsors

Universiti Teknologi MARA
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Systematically healthy adult patients diagnosed with Chronic Periodontitis Stage III and IV Grade A/B/C, aged between 30-65 years old 2. Patient with deep periodontal pocket, at least two quadrants with pocket >5 mm 3. Patients who have not received antibiotic therapy within the last 3 months 4. Patients who have no known allergy to medications 5. Patients with at least 10 teeth in each jaw

Exclusion criteria

Exclusion criteria: 1. Patients with contraindications to TAP or specific antibiotic content such as patients with a history of seizures, myasthenia gravis, peripheral neuropathy, liver and kidney problems 2. Pregnant or lactating individuals 3. Patients on systemic antibiotics past 3 months 4. Smoking more than 10 cigarettes per day 5. Patients with a history of diabetes, cardiovascular disease and immune disorder 6. History of hypersensitivity to metronidazole, or minocycline, or ciprofloxacin 7. Patients on immunosuppressant in the last 6 months 8. Periodontal treatment done in the last 6 months

Design outcomes

Primary

MeasureTime frame
Measured at baseline, 8 weeks and 3 months postoperatively using UNC-15 periodontal probe: 1. Pocket depth 2. Plaque reduction 3. Bleeding on probing 4. Clinical attachment level

Secondary

MeasureTime frame
Measured using relative quantification at baseline and 8 weeks postoperatively: 1. Levels of IL-1ß, IL-6, IL-10 and TNF-a measured using the Luminex fluorescent technique, utilizing Milliplex Magnetic Beads (Merck Millipore, BA, USA) 2. Aggregatibacter actinomycetemcomitans (Aa) and Porphyromonas gingivalis (Pg) count using relative qPCR

Countries

Malaysia

Contacts

Public ContactNursafirah 'izzati Binti;Muhammad Hilmi Bin Idrus;Zainal Ariffin

;

2023600476@student.uitm.edu.my;muhammadhilmi@uitm.edu.my+60 (0)13-9608480;+60 (0)193674088

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026